You put things so eloquently Ted, it's poetry in motion.
As big as OSA and TBI will be potentially, this will monster those if trials go our way - as Ted mentioned, this is a massive unmet need and it's not just restricted to COVID, you've got pneumonia, sepsis, pancreatitis etc etc. that lead to SAARDS and eventually death or permanent damage if one is fortunate.
HERO or ZERO, the beauty of where we are currently is that it's no longer speculation, the company is in execution mode and we will have an answer within 4 / 5 weeks. If things don't go our way here, we have another 3 bites of the cherry with TBI/OSA/TMJ and then we have our oil sales, which the way things are progressing, would make this company more than viable without even talk of trials - definitely not a one trick pony here.
- Forums
- ASX - By Stock
- IHL
- Ann: IHL commences IHL-675 (ARDS) animal study
Ann: IHL commences IHL-675 (ARDS) animal study, page-45
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online